Human isolated coronary artery contraction to sumatriptan: A post hoc analysis

Cephalalgia

Volumn 19, Issue 7, 1999, Pages 651-654

  MaassenVanDenBrink, A ^c   Bax, W A ^a   Ramrattan, N N ^c   Ferrari, M D ^c   Saxena, P R ^b  

^a EEMLAND HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

Age; Endothelium; Human coronary artery; Migraine therapy; Sumatriptan

Indexed keywords

SUMATRIPTAN;

ADULT; AGE; ARTERY ENDOTHELIUM; ARTICLE; CORONARY ARTERY CONSTRICTION; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; HUMAN TISSUE; MALE; VASOCONSTRICTION;

ADULT; AGED; CAUSE OF DEATH; CHEST PAIN; CORONARY DISEASE; CORONARY VESSELS; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0032829246     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1999.019007651.x     Document Type: Article

References (20)

1. Ferrari MD. Migraine. Lancet 1998;351:1043-51
2. Brown EG, Endersby CA, Smith RN, Talbot JCC. The safety and tolerability of sumatriptan: an overview. Eur Neurol 1991;31:339-44
3. Visser WH, Jaspers NM, de Vriend RH, Ferrari MD. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgia 1996;16:554-9
4. Houghton LA, Foster JM, Whorwell PJ, Morris J, Fowler P. Is chest pain after sumatriptan oesophageal in origin? Lancet 1994;344:985-6
5. 1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993;87:401-5
6. Maassen Van Den Brink A, Bax WA, Ferrari MD, Zijlstra FJ, Bos E, Saxena PR. Augmented contraction of the human isolated coronary artery by sumatriptan; a possible role for endogenous thromboxane. Br J Pharmacol 1996;119:855-62
7. 1Dβ receptors. Circulation 1994;90:1141-53
8. Bax WA, Renzenbrink GJ, van Heuven-Nolsen D, Thijssen HJM, Bos E, Saxena PR. 5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol 1993;239:203-10
9. 2 receptor activation. Eur J Pharmacol 1989;161:91-4
10. Ottervanger JP, Paalman HJA, Boxma GL, Stricker BHC. Transmural myocardial infarction with sumatriptan. Lancet 1993;341:861-62
11. O'Connor P, Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology 1995;45:2274-6
12. Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache 1996;36:329-31
13. Main ML, Ramaswamy K, Andrews TC. Cardiac arrest and myocardial infarction immediately after sumatriptan injection. Arm Intern Med 1998;128:874
14. Kelly KM. Cardiac arrest following use of sumatriptan. Neurology 1995;45:1211-3
15. Ottervanger JP, Valkenburg HA, Stricker BHC, Grobbee DE. Determinants of sumatriptan-induced chest pain. Pharmacy World Sci 1995;17:16
16. Chester AH, Martin GR, Bodelsson M, et al. 5-Hydroxytriptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res 1990;24:932-7
17. De Lean A, Munson PJ, Robbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-102
18. Chester AH, O'Neil GS, Tadjkarimi S, Palmer RM, Moncada S, Yacoub MH. The role of nitric oxide in mediating endothelium dependent relaxations in the human epicardial coronary artery. Int J Cardiol 1990;29:305-9
19. Nilsson T, Longmore J, Shaw D, et al. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol 1999;372:49-56
20. Maassen Van DenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998;98:25-30